Nano-X Imaging (NNOX) EBITDA Margin (2022 - 2026)
Nano-X Imaging's (NNOX) quarterly EBITDA Margin came in at 337.69% in Q1 2026, up 16284.0% on a YoY basis from N/an in Q1 2025, and up 64.54% quarter-over-quarter from 952.35% in Q4 2025.
Powered by 
Analysis
Nano-X Imaging (NNOX) EBITDA Margin (2022 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported EBITDA Margin for 5 consecutive years, with 337.69% the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 16284.0% year-over-year to 337.69%; the trailing twelve-month figure through Mar 2026 stood at 540.08% (down 4259.0% YoY), and the FY2025 full-year result was 600.83%, down 9790.0% from the prior year.
- EBITDA Margin climbed to 337.69% in Q1 2026 per NNOX's latest filing, from 952.35% in the prior quarter.
- Across five years, EBITDA Margin topped out at 337.69% in Q1 2026 and bottomed at 2521.39% in Q4 2022.
- Historically, EBITDA Margin has averaged 750.07% across 5 years, with a median of 514.1% in 2024.
- The sharpest annual moves came in 2023 and 2025: EBITDA Margin jumped 207554 bps in 2023, then tumbled 45319 bps in 2025.
- Over 5 years, EBITDA Margin stood at 2521.39% in 2022, then jumped by 82 bps to 445.85% in 2023, then declined by 12 bps to 499.17% in 2024, then tumbled by 91 bps to 952.35% in 2025, then soared by 65 bps to 337.69% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 337.69%, 952.35%, and 412.97% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 13.96% |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 25.82% |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | -27.93% |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 1.38% |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | -41.90% |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | -71.11% |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 10.83% |
| 10 | Nano-X Imaging | 57.76 Mn | 13.54 Mn | -2.59 Mn | -337.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -337.69% |
| Dec 31, 2025 | -952.35% |
| Sep 30, 2025 | -412.97% |
| Jun 30, 2025 | -466.84% |
| Mar 31, 2025 | -500.53% |
| Dec 31, 2024 | -499.17% |
| Sep 30, 2024 | -466.48% |
| Jun 30, 2024 | -527.27% |
| Mar 31, 2024 | -514.10% |
| Dec 31, 2023 | -445.85% |
| Sep 30, 2023 | -887.17% |
| Jun 30, 2023 | -690.59% |
| Mar 31, 2023 | -493.58% |
| Dec 31, 2022 | -2,521.39% |
| Sep 30, 2022 | -813.33% |
| Jun 30, 2022 | -1,008.32% |
| Mar 31, 2022 | -1,213.61% |